Status:
UNKNOWN
EPIdemiological Approaches to the Cardiovascular Consequences of COVID-19
Lead Sponsor:
Centre Hospitalier Universitaire Dijon
Conditions:
Acute Myocardial Infarction
Eligibility:
All Genders
18+ years
Brief Summary
The COVID-19 pandemic highlights the importance of the prognosis of co-morbidities, such as coronary artery disease, which significantly increase the risk of mortality in patients infected with SARS-C...
Eligibility Criteria
Inclusion
- patients hospitalized for a type 2 MI in CCU from CHU Dijon Bourgogne With or without pneumonia
- patients hospitalized for a type 2 MI in CCU from CHU Dijon Bourgogne With or without COVID 19
Exclusion
- None
Key Trial Info
Start Date :
March 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2021
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT04498091
Start Date
March 15 2020
End Date
July 1 2021
Last Update
August 4 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Dijon Bourgogne
Dijon, France, 21000